Table 2.
Men | Women | ||||
---|---|---|---|---|---|
Total of Positive Samples Among All 105 Visits, N (%) |
Range of % Positive Sample Among Visits 1–5 | Total of Positive Samples Among All 105 Visits, N (%) |
Range of % Positive Samples Among Visits 1–5 | ||
Hand | 72 (69) | 57–81b | Hand | 69 (66) | 62–71b |
Shaft | 52 (50) | 29–57c | Vulva | 22 (21) | 14–29b |
Scrotum | 43 (41) | 29–52d | Vagina | 15 (14) | 5–24b |
Glans | 30 (29) | 19–38b | CVL | 15 (14) | 5–19b |
Perianal | 22 (21) | 14–29b | Anal | 15 (14) | 5–24b |
Oral | 16 (15) | 10–24b | Oral | 6 (6) | 0–14e |
Foreskina | 9 (41) | 0–67e | Anogenitalg | 43 (41) | 33–57b |
Semen | 2 (2) | 0–5e | |||
Anogenitalg | 70 (67) | 38–81f |
Abbreviations: HPV, human papillomavirus; CVL, cervical vaginal lavage; V, visit.
aFour men were uncircumcised.
bNo differences were seen between visits.
cHigher rates were seen at V2 (P < .05), V4 (P < .05), and V5 (P < .05) compared with V1.
dHigher rates were seen at V3 compared with V1 (P < .05).
eToo few samples positive for comparison.
fV1 had lower rates than V2, V3, and V4 (Ps < .05).
gAnogenital excludes oral and hand sites.